• Mashup Score: 0

    The traditional path to a career in hematology in the U.S. involves at least nine years of graduate-level training, starting with medical school and ending with a hematology or combined hematology-oncology fellowship that is certified by the Accreditation Council for Graduate Medical Education (ACGME), which accredits teaching hospitals, residencies, and fellowships. However, a small number of…

    Tweet Tweets with this article
    • Read the July Feature Article from @ASHClinicalNews, which discusses the considerations of whether to pursue advanced, non-ACGME accredited fellowships for #hematologists interested in specialized areas of practice: https://t.co/6o1IVnNg0P #Hematology https://t.co/WKAFct5VN7

  • Mashup Score: 0

    As a Latin woman, walking into a large medical conference can be a lonely experience. But Jacqueline C. Barrientos, MD, said that feeling faded away for her at the American Society of Hematology (ASH) Annual Meeting when she entered a room full of hematologists who were current or former recipients of research awards granted through the Society’s Minority Recruitment Initiative (MRI), a program…

    Tweet Tweets with this article
    • This year, the @ASH_hematology Minority Recruitment Initiative (MRI) celebrates 20 years of support and mentorship for underrepresented #hematologists. See what past awardees have to say and learn how one MRI award has served as a model for others: https://t.co/0DYMHGrqEP

  • Mashup Score: 0

    The term “cultural competence” has been used in medicine for decades, with physicians aiming to deliver care that addresses a patient’s social, cultural, and language needs.1 But as the medical community – and society as a whole – grapples with complex issues like how to achieve equity and tackle structural racism, the conversation is turning to different terms, such as cultural sensitivity and…

    Tweet Tweets with this article
    • When #hematologists practice cultural sensitivity, it can help ensure their patients feel heard and respected, which in turn can positively affect treatment outcomes. https://t.co/plnzNifYRE

  • Mashup Score: 0

    The term “cultural competence” has been used in medicine for decades, with physicians aiming to deliver care that addresses a patient’s social, cultural, and language needs.1 But as the medical community – and society as a whole – grapples with complex issues like how to achieve equity and tackle structural racism, the conversation is turning to different terms, such as cultural sensitivity and…

    Tweet Tweets with this article
    • When #hematologists practice cultural sensitivity, it can help ensure their patients feel heard and respected, which in turn can positively affect treatment outcomes. https://t.co/Ddukxf2tZC

  • Mashup Score: 0

    PURPOSE: Conventional hematology/oncology fellowship training is designed to foster careers in academic practice through intensive exposure to clinical and laboratory research. Even so, a notable proportion of graduating fellows opt to pursue a clinically focused career outside the realm of academic medicine. Given the corresponding shortage of oncologists in nonurban and rural settings,…

    Tweet Tweets with this article
    • 🚨🔥Hot off the press. Just published @JCOOP_ASCO @ASCO Very important article/project on: Training #Hematologists/#Oncologists for the Academic-Community Hybrid: Creating a #Fellowship Framework for the Future. 👇🏼 https://t.co/nlU2BYt7YZ #MedEd #OncMedEd #OncTwitter https://t.co/LyNw46yS6f

  • Mashup Score: 4
    Wolters Kluwer Health - 2 year(s) ago

    JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…

    Tweet Tweets with this article
    • In this installment of Colleague Conversations, #HemOnc Times sat down with @doctorpemm and @MrinalPatnaik who have both dedicated their careers to the study of rare and ultra-rare cancers: https://t.co/8mxcsqwr99 #hematologists #rarecancers #BPDCN #CMML https://t.co/BwTOZEfsVM